Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

USCI medical loboratary

Request full access

Clinical molecular diagnostics for oncology and reproductive health

Haidian, ChinaFounded 2015

About USCI medical loboratary

USCI Medical Laboratory, also known as UGENIX Biotech, is a Beijing-based biotechnology company specializing in clinical molecular testing. Founded in 2015, the company operates in three primary areas: reproductive health (prenatal testing), precision oncology, and pathogen detection. USCI Medical provides a range of services and products, including non-invasive prenatal testing (NIPT) for chromosomal abnormalities and liquid biopsy platforms (ctDNA and CTC) for cancer screening, diagnosis, and monitoring. The company has developed its own proprietary technologies, such as the ESRiT technique for high-depth sequencing, and has received regulatory approval for its own branded DNA sequencers, the USCISEQ-200 and USCISEQ-2000.

The company's first operating entity was established in 2011. In 2016, Wang Jianwei, who previously held roles at BGI (Hua-Da-Ji-Yin) and Annoroad Gene Technology (An-Nuo-You-Da), joined as president and later took a controlling interest. The current CEO is Dr. Wu Qixi, a Peking University cell biology doctorate holder, and the CTO is Dr. Zhao Hanqing, who holds a doctorate in bioinformatics from the same institution. The company serves over 1,500 medical institutions across more than 30 provinces in China.

USCI Medical follows a dual-track business model combining Laboratory Developed Tests (LDT) with In-Vitro Diagnostic (IVD) product development and manufacturing. The company has established R&D and GMP production bases in both Beijing and Hangzhou. It has secured significant funding through multiple rounds, with its latest round in May 2022 raising its total to over $31.3 million and involving investors such as Decheng Capital, Infinity Group, and BGI. The company submitted an application to list on the Hong Kong Stock Exchange in April 2024.

Source: Dealroom company data

USCI medical loboratary in the Haidian ecosystem

Live from Dealroom

The USCI medical loboratary office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • ShenZhen GTJA Investment Group
  • K2VC

Series B and later3 investors entered at this stage

  • Decheng Capital
  • Infinity Group
  • Beijing Zhongguancun Overseas Science Park Co.Ltd
Employees 18 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about USCI medical loboratary on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See USCI medical loboratary on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.